•  
  •  
  •  
  •  

2025-11-16 08:41:57

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Karnataka Bank appoints Veteran Banker Mr Raghavendra S Bhat as its New Managing Director & CEO
  • Websol signs MoU with Andhra Pradesh Economic Development Board
  • Sellwin Traders Ltd has signed MOU to acquire 36% Equity Stake in Kumkum Wellness
  • Western Carriers Reports Q2 & H1 FY26 Results
  • Lupin announces closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facility with No Observations

Keywords Selected:  Approval

IPO News

  • VMS TMT Limited Gets SEBI Nod to Float an IPO
  • Rachit Prints Limited receives in-principle approval from BSE SME Exchange, Plans to Raise ₹19.50 Crore
  • Icon Facilitators Announces BSE SME IPO Approval, Targets ₹22 Crore Fundraise
  • Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
  • Jungle Camps India Limited plans to raise around Rs. 30 crores from IPO
  • Senores Pharmaceuticals gets Sebi nod for IPO
  • Telangana-based Standard Glass Lining Technology Limited gets Sebi nod for IPO
  • IT Solutions provider Orient Technologies gets Sebi nod for IPO
  • Gala Precision Engineering gets Sebi nod for IPO
  • Noida-based Interarch Building Products Limited gets SEBI nod for IPO
  • Nephro Care India Limited plans to raise Rs. 35-40 crore from its upcoming IPO
  • Allied Blenders and Distillers Limited gets Sebi nod for Rs 1500 crore IPO
  • Sanstar Limited, gets SEBI nod to float IPO
  • Asirvad Micro Finance Limited gets Sebi nod for IPO
  • Kronox Lab Sciences gets SEBI nod to float IPO
  • Fairfax-backed Go Digit General Insurance gets Sebi nod for IPO
  • Gopal Snacks Limited gets Sebi nod for Rs 650 crore IPO
  • Juniper Hotels gets Sebi nod for its Rs 1,800 crore IPO
  • Stanley Lifestyles gets Sebi nod for IPO
  • Onest and Shiva Pharmachem gets Sebi nod for IPO
  • Mukka Proteins Limited gets Sebi Nod for IPO
  • Ludhiana-based Auto Component Maker Happy Forgings Limited receives Sebi nod to float its IPO
  • Cello World Limited gets Sebi nod for its Rs 1750 crore IPO
  • ESAF Small Finance Bank gets Sebi nod for IPO

Stock Report

  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
  • Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
  • Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval Dexlansoprazole Delayed Release Capsules, 30 mg and 60 mg
  • Zydus receives approval from China's NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg
  • Glenmark Secures China Approval For RYALTRIS®, Reinforcing Respiratory Innovation Leadership
  • Zydus receives tentative approval from USFDA for Olaparib Tablets, 100 mg and 150 mg
  • Ram Ratna Wires Ltd. bags approval under Rajasthan Investment Promotion Scheme for Bhiwadi Plant
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Sumatriptan Injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, Single-Dose Autoinjector System
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg
  • Zydus receives tentative approval from USFDA for Budesonide delayedrelease capsules, 4 mg
  • KPI Green Energy Ltd receives charging approval for 40.96 MW hybrid power projects
  • Godrej Properties receives RERA approval for Phase 1 of Godrej Trilogy in Worli, Mumbai
  • Zydus receives approval from Health Canada for Mesalamine suppositories
  • Mangalya SoftTech Ltd is now Ratnakar Securities Ltd
  • Caplin Steriles Ltd receives USFDA approval for ANDA Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection
  • Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V., a Biosimilar to Stelara®
  • MIC Electronics Limited receives approval of fresh registration from RDSO
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Triamcinolone Acetonide Injectable Suspension USP, 40 mg/mL
  • Relonchem Limited receives Marketing Authorization for two of its products
  • Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility
  • Standard Capital Markets Ltd commences Trading in Corporate Bonds after Obtaining CBRICS Registration from NSE
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets

Industry News

  • RBI grants NBFC license to Equirus Group
  • NCLT approves slice and North East Small Finance Bank's Merger
  • NSE launches WTI Crude Oil and Natural Gas futures contracts
  • Zero To One, an angel network, gets SEBI nod to launch INR 300cr Alternative Investment Fund
  • Pre Construction Tips: Things to Check
  • NTT DATA Payment Services accorded approval by RBI for payment aggregator license
  • Insurance product approvals made easy - Steps towards ease of doing business

Latest Post

  • Karnataka Bank appoints Veteran Banker Mr Raghavendra S Bhat as its New Managing Director & CEO
  • Websol signs MoU with Andhra Pradesh Economic Development Board
  • Sellwin Traders Ltd has signed MOU to acquire 36% Equity Stake in Kumkum Wellness
  • Western Carriers Reports Q2 & H1 FY26 Results
  • Lupin announces closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facility with No Observations


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024